Otolaryngology · New York, NY
NPI
1669585394
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
36a East 36 Street, Suite 200
New York, NY, 10016
Phone (212) 889-8575
Groups this clinician bills Medicare through
Medicare paid, 2024
$262K
3,088 services
Medicare patients, 2024
953
Average age 78
Drug cost, 2024
$39K
1,911 prescriptions
Company payments, 2025
$107
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott D Gold was code 99213 (office e&m - established), 1,084 times for 603 patients. In total Scott D Gold billed 3,088 services in 14 codes, and Medicare paid $262K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,084 | 603 | $77.07 | $84K |
| 69210 Other Organ Systems | Office | 712 | 511 | $35.52 | $25K |
| 31575 Other Organ Systems | Office | 510 | 307 | $117.47 | $60K |
| 31231 Nasal/Sinus Endoscopy | Office | 339 | 218 | $169.48 | $57K |
| 99203 Office E&M - New | Office | 259 | 258 | $90.87 | $24K |
| 99212 Office E&M - Established | Office | 110 | 100 | $41.83 | $4,602 |
| 99202 Office E&M - New | Office | 23 | 23 | $55.58 | $1,278 |
| 99214 Office E&M - Established | Office | 20 | 20 | $116.74 | $2,335 |
| 30901 Other Organ Systems | Office | 15 | 11 | $153.34 | $2,300 |
By year: 2022 $259K for 2,604 services; 2023 $267K for 3,026 services; 2024 $262K for 3,088 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott D Gold prescribed most often to Medicare patients was Famotidine, with 906 prescriptions and refills. In total Scott D Gold wrote 1,911 Medicare prescriptions that cost $39K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 906 | 1,218 | 264 | $8,410 |
| Ipratropium Bromide Generic | 172 | 214 | 56 | $3,780 |
| Pantoprazole Sodium Generic | 90 | 148 | 18 | $777 |
| Fluocinolone Acetonide Oil Generic | 89 | 146 | 60 | $3,672 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 84 | 84 | 66 | $713 |
| Azelastine Hcl Generic | 82 | 105 | 34 | $1,719 |
| Fluticasone Propionate Generic | 75 | 105 | 33 | $743 |
| Prednisone Generic | 50 | 50 | 41 | $100 |
| Omeprazole Generic | 38 | 52 | Under 11 | $301 |
| Amitriptyline Hcl Generic | 38 | 40 | Under 11 | $125 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 30 | 38 | 11 | $3,309 |
| Mometasone Furoate Generic | 27 | 27 | 11 | $1,727 |
| Azithromycin Generic | 26 | 26 | 21 | $125 |
| Doxycycline Hyclate Generic | 23 | 23 | 20 | $248 |
| Ofloxacin Generic | 22 | 22 | 16 | $313 |
Brand drugs: - claims; generic drugs: 1,875 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott D Gold $107 ($107 in general payments such as food, travel and fees) from 1 company. The largest payer was Smith+Nephew, Inc. with $107.
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. SNN | 1 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.